105 related articles for article (PubMed ID: 31357239)
21. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
23. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
[TBL] [Abstract][Full Text] [Related]
24. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
[TBL] [Abstract][Full Text] [Related]
25. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
[TBL] [Abstract][Full Text] [Related]
26. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
Renner SP; Strick R; Fasching PA; Oeser S; Oppelt P; Mueller A; Beckmann MW; Strissel PL
Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma.
Hsieh YY; Chang CC; Tsai FJ; Tsai HD; Yeh LS; Lin CC; Tsai CH
Fertil Steril; 2003 Jan; 79(1):96-9. PubMed ID: 12524070
[TBL] [Abstract][Full Text] [Related]
28. Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas.
Massart F; Becherini L; Gennari L; Facchini V; Genazzani AR; Brandi ML
Fertil Steril; 2001 Mar; 75(3):567-70. PubMed ID: 11239543
[TBL] [Abstract][Full Text] [Related]
29. TP53 polymorphism in plasma cell myeloma.
Zmorzynski SA; Korszen-Pilecka I; Wojcierowska-Litwin M; Kwiatkowska-Drabik B; Luterek M; Chocholska S; Koczkodaj D; Popek S; Michalak-Wojnowska M; Swiderska-Kolacz G; Januszewska J; Surowiec I; Tomczak W; Hus M; Dmoszynska A; Pasiarski M; Poniewierska-Jasak K; Cieplinska K; Jankowska-Lecka O; Filip AA
Folia Histochem Cytobiol; 2017; 55(4):203-211. PubMed ID: 29333597
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.
Rosa FE; Canevari Rde A; Ambrosio EP; Ramos Cirilo PD; Pontes A; Rainho CA; Rogatto SR
Clin Chem Lab Med; 2008; 46(6):814-23. PubMed ID: 18601603
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas.
Hall KL; Teneriello MG; Taylor RR; Lemon S; Ebina M; Linnoila RI; Norris JH; Park RC; Birrer MJ
Gynecol Oncol; 1997 May; 65(2):330-5. PubMed ID: 9159347
[TBL] [Abstract][Full Text] [Related]
34.
Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
[No Abstract] [Full Text] [Related]
35. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
36. Association of ACE I/D and AGTR1 A1166C Gene Polymorphisms and Risk of Uterine Leiomyoma: A Case-Control Study.
Keshavarzi F; Teimoori B; Farzaneh F; Mokhtari M; Najafi D; Salimi S
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2595-2599. PubMed ID: 31554351
[TBL] [Abstract][Full Text] [Related]
37. Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.
Salimi S; Sajadian M; Khodamian M; Yazdi A; Rezaee S; Mohammadpour-Gharehbagh A; Mokhtari M; Yaghmaie M
Bosn J Basic Med Sci; 2016 Aug; 16(3):209-14. PubMed ID: 27333216
[TBL] [Abstract][Full Text] [Related]
38. [MED12 gene mutations in women with uterine myoma].
Osinovskaya NS; Ivashchenko TE; Dolinskii AK; Sultanov IY; Ghimbovchi S; Hoffman E; Bezhenar VF; Baranov VS
Genetika; 2013 Dec; 49(12):1426-31. PubMed ID: 25438604
[TBL] [Abstract][Full Text] [Related]
39. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas.
Bondagji NS; Morad FA; Al-Nefaei AA; Khan IA; Elango R; Abdullah LS; M Al-Mansouri N; Sabir J; Banaganapalli B; Edris S; Shaik NA
J Obstet Gynaecol Res; 2017 Feb; 43(2):330-338. PubMed ID: 27987337
[TBL] [Abstract][Full Text] [Related]
40. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
Hsieh YY; Wang JP; Lin CS
Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]